Digital Health Global
SEPTEMBER 19, 2023
The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xealth
JUNE 27, 2023
Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Don’t wait until you have a “fully-baked” digital health strategy to begin weighing the pros and cons of DTx implementation.
Healthcare IT Today
JANUARY 8, 2024
It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.
Digital Health Global
AUGUST 30, 2023
QuantHealth bridges these gaps by simulating trials at scale, to expedite, derisk, and optimize drug development. This decline is happening at a time when the need for efficient drug development has never been greater. This happens because there are major gaps in the research needed to support clinical trials.
Healthcare IT Today
JANUARY 9, 2023
Unstructured data plays a greater role in healthcare strategies and improves patient outcomes: Unstructured data, such as physician notes, x-rays or even social media sentiment – which some estimates suggest represents as much as 80% of healthcare data – has long been a white whale in the healthcare world.
Society for Participatory Medicine
FEBRUARY 1, 2023
The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
Expert insights. Personalized for you.
167 
Let's personalize your content